Clinical trial

Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy

NCT02129985

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-02-01

PhasePHASE4

Study timeline

Study start (unknown)2014-02-01Date precision: month

Registry last updated2014-05-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

ExenatideDRUG · verified · RxNorm: exenatide

MetforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

xiaolong zhaolead sponsor

Shanghai Zhongshan Hospitalcollaborator

The third people's Hospital Affiliated to Shanghai Jiao Tong Universitycollaborator

Second Affiliated Hospital of Soochow Universitycollaborator

The First Hospital of Guiyang Medical collegecollaborator

Fuling Central Hospital of Chongqing Citycollaborator

Taizhou Hospitalcollaborator

Shanghai Pudong New Area Gongli Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02129985 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.